Author: Riou, Marianne; MarcoT, Christophe; Oulehri, Walid; Enache, Irina; Pistea, Cristina; Chatron, Eva; Labani, Aissam; Geny, Bernard; Ohana, Mickael; De Blay, Frederic; Kessler, Romain; Charloux, Anne
Title: Respiratory followâ€up after hospitalization for COVIDâ€19: Who and when? Cord-id: qi4omjw8 Document date: 2021_6_4
ID: qi4omjw8
Snippet: Despite more than 148 million infected people, coronavirus disease 2019 (COVID-19) respiratory intermediate and long-term survivors' outcome remains largely unknown. Lungs are the main COVID-19 target organ, and 5-10% patients progress to critical disease including acute respiratory distress syndrome (ARDS) [1]. Pulmonary function tests (PFT) performed at discharge from hospital showed that >80% of severe COVID-19 patients had lung function impairment [2].
Document: Despite more than 148 million infected people, coronavirus disease 2019 (COVID-19) respiratory intermediate and long-term survivors' outcome remains largely unknown. Lungs are the main COVID-19 target organ, and 5-10% patients progress to critical disease including acute respiratory distress syndrome (ARDS) [1]. Pulmonary function tests (PFT) performed at discharge from hospital showed that >80% of severe COVID-19 patients had lung function impairment [2].
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and lung function impairment: 1, 2, 3
- long intermediate and lung function: 1
- long intermediate term and lung function: 1
Co phrase search for related documents, hyperlinks ordered by date